StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.87+0.26 (+5.64%)

Close on Nov 18, 2026Market cap $61.16MP/E –Yield –

Neuraxis operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Neuraxis's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.62M. For fiscal 2025 it was -$6.43M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.43M–
FY2024Dec 31, 2024-$6.10M–
FY2023Dec 31, 2023-$6.69M–
FY2022Dec 31, 2022-$2.30M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.03M–
Q1 FY2026Mar 31, 2026-$1.23M–
Q4 FY2025Dec 31, 2025-$1.93M–
Q3 FY2025Sep 30, 2025-$1.43M–
Q2 FY2025Jun 30, 2025-$1.47M–
Q1 FY2025Mar 31, 2025-$1.60M–
Q4 FY2024Dec 31, 2024-$1.76M–
Q3 FY2024Sep 30, 2024-$1.39M–
Q2 FY2024Jun 30, 2024-$1.62M–
Q1 FY2024Mar 31, 2024-$1.33M–
Q4 FY2023Dec 31, 2023-$2.63M–
Q3 FY2023Sep 30, 2023-$2.82M–
Q2 FY2023Jun 30, 2023-$625.23K–
Q1 FY2023Mar 31, 2023-$622.91K–
Q4 FY2022Dec 31, 2022-$214.32K–
Q3 FY2022Sep 30, 2022-$911.79K–

More Neuraxis figures

See a number that looks wrong?